Perioperative DKA linked to SGLT2i Therapy: The enigmas of preprocedural handling, diagnosis, and event rate estimation.
作者信息
Thiruvenkatarajan Venkatesan, Nanjappa Nagesh, Jesudason David, Meyer Emily J, Van Wijk Roelof M, Dharmalingam Ashok
机构信息
Department of Anaesthesia, The Queen Elizabeth Hospital, Woodville, Discipline of Acute Care Medicine, The University of Adelaide, South Australia, Australia.
Department of Endocrinology and Diabetes, The Metabolic Unit, The Queen Elizabeth Hospital, Woodville, Department of Endocrinology and Metabolic Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, South Australia, Australia.
出版信息
Ann Card Anaesth. 2023 Jul-Sep;26(3):361-362. doi: 10.4103/aca.aca_183_22.
Abstract
摘要
相似文献
1
Perioperative DKA linked to SGLT2i Therapy: The enigmas of preprocedural handling, diagnosis, and event rate estimation.围手术期糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂治疗相关：术前处理、诊断及事件发生率估计的谜团
Ann Card Anaesth. 2023 Jul-Sep;26(3):361-362. doi: 10.4103/aca.aca_183_22.
2
SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂：对原发性文献中糖尿病酮症酸中毒及相关危险因素的系统评价
Pharmacotherapy. 2017 Feb;37(2):187-194. doi: 10.1002/phar.1881. Epub 2017 Jan 16.
3
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.钠-葡萄糖共转运蛋白 2 抑制剂与糖尿病酮症酸中毒：文献更新综述。
Diabetes Obes Metab. 2018 Jan;20(1):25-33. doi: 10.1111/dom.13012. Epub 2017 Jul 6.
4
Hospitalization of Patients With Diabetes Due to Ketoacidosis Before and After the Initiation of Sodium-Glucose Cotransporter-2 Inhibitors.钠-葡萄糖共转运蛋白 2 抑制剂启用前后糖尿病酮症酸中毒患者的住院情况。
Endocr Pract. 2023 Sep;29(9):686-691. doi: 10.1016/j.eprac.2023.06.010. Epub 2023 Jul 11.
5
SGLT2i in Patients with Type 1 Diabetes: Benefits, Risks, and Preventive Strategies.SGLT2i 在 1 型糖尿病患者中的应用：获益、风险和预防策略。
Front Biosci (Landmark Ed). 2023 May 22;28(5):98. doi: 10.31083/j.fbl2805098.
6
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病酮症酸中毒：来自美国食品药品监督管理局不良事件报告系统的数据
Diabetologia. 2017 Aug;60(8):1385-1389. doi: 10.1007/s00125-017-4301-8. Epub 2017 May 12.
7
Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents.使用SGLT2抑制剂及其他降糖药物治疗的2型糖尿病患者中糖尿病酮症酸中毒的发生率。
Diabetes Res Clin Pract. 2017 Jun;128:83-90. doi: 10.1016/j.diabres.2017.04.004. Epub 2017 Apr 13.
8
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.1 型糖尿病中钠-葡萄糖共转运蛋白 2 抑制作用的真实世界评估及糖尿病酮症酸中毒风险。
Diab Vasc Dis Res. 2022 Sep-Oct;19(5):14791641221130043. doi: 10.1177/14791641221130043.
9
Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.SGLT2 抑制剂治疗的 2 型糖尿病患者出现血糖水平低于预期的糖尿病酮症酸中毒的易感因素：综述。
Eur J Clin Pharmacol. 2021 May;77(5):651-657. doi: 10.1007/s00228-020-03051-3. Epub 2020 Nov 26.
10
SGLT2i increased the plasma fasting glucagon level in patients with diabetes: A meta-analysis.SGLT2i 增加了糖尿病患者的空腹血浆胰高血糖素水平：一项荟萃分析。
Eur J Pharmacol. 2021 Jul 15;903:174145. doi: 10.1016/j.ejphar.2021.174145. Epub 2021 May 3.
本文引用的文献
1
A retrospective analysis of the incidence, outcome and factors associated with the occurrence of euglycemic ketoacidosis in diabetic patients on sodium glucose co-transporter - 2 inhibitors undergoing cardiac surgery.回顾性分析心脏手术中使用钠-葡萄糖共转运蛋白 2 抑制剂的糖尿病患者发生血糖正常性酮症酸中毒的发生率、结局和相关因素。
Ann Card Anaesth. 2022 Oct-Dec;25(4):460-465. doi: 10.4103/aca.aca_47_21.
2
Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy.结肠镜检查期间与钠-葡萄糖协同转运蛋白2抑制剂治疗相关的围手术期正常血糖性糖尿病酮症酸中毒
Diabetes Care. 2020 Nov;43(11):e181-e184. doi: 10.2337/dc20-1244. Epub 2020 Sep 17.
3
Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.与钠-葡萄糖共转运蛋白 2 抑制剂相关的围手术期糖尿病酮症酸中毒：系统评价。
Br J Anaesth. 2019 Jul;123(1):27-36. doi: 10.1016/j.bja.2019.03.028. Epub 2019 May 3.
4
Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations.钠-葡萄糖协同转运蛋白 2 抑制剂：药理学和围手术期注意事项。
Anaesthesia. 2018 Aug;73(8):1008-1018. doi: 10.1111/anae.14251. Epub 2018 Mar 12.
Zotero 插件